AEHR TEST SYSTEMS
For the period ended May 30, 2025. Filed Jul 28, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Jul 28, 2025
AEHR$59.57-0.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibits and Financial Statement Schedules
(a) The following documents are filed as part of this Report:
| 1. | Financial Statements |
| See Index under Item 8. | |
|---|---|
| 2. | Financial Statement Schedule |
| None. | |
| 3. | Exhibits |
| See Item 15(b) below. | |
(b) Exhibits
The following exhibits are filed as part of or incorporated by reference into this Report:
| Exhibit No. | Description |
| 3.1(1) | Restated Articles of Incorporation of Registrant. |
| 3.2(2) | Amended and Restated Bylaws of Registrant. |
| 4.1(3) | Form of Common Stock certificate. |
| 4.2(4) | Registration Rights Agreement by and among the Company and the Investors (as defined therein), dated as of September 22, 2016. |
| 4.3(5) | Description of Securities |
| 10.1(6) | Amended and Restated 2006 Employee Stock Purchase Plan.* |
| 10.2(7) | 2016 Equity Incentive Plan.* |
| 10.3(8) | Form of Indemnification Agreement entered into between Registrant and its directors and executive officers.* |
| 10.4(9) | Form of Change of Control Agreement.* |
| 10.5(10) | Lease dated August 3, 1999 for facilities located at Building C, 400 Kato Terrace, Fremont, California. |
| 10.6(11) | First Amendment dated May 06, 2008 for facilities located at 400 Kato Terrace, Fremont, California. |
| 10.7(12) | Second Amendment dated November 7, 2014 for facilities located at 400 Kato Terrace, Fremont, California. |
| 10.8(13) | Third Amendment dated February 27, 2018 for facilities located at 400 Kato Terrace, Fremont, California. |
| 10.9(14) | Offer Letter dated January 3, 2012, between the Company and Gayn Erickson.* |
| 10.10(15) | Offer Letter dated March 5, 2013, between the Company and Rhea Posedel.* |
| 10.11(16) | Form of Change in Control and Severance Agreement by and between Aehr Test Systems and its executive officers.* |
| 10.12(17) | Amended and Restated Change of Control Severance Agreement dated March 5, 2013, between the Company and Rhea J. Posedel.* |
| 10.13(18) | Form of 2016 Equity Incentive Plan Stock Option Award Agreement.* |
| 10.14(19) | Form of 2016 Equity Incentive Plan Restricted Stock Unit Award.* |
| 10.15(20) | Purchase Agreement by and among the Company and the Investors (as defined therein), dated as of September 22, 2016. |
| 10.16(21) | Equity Distribution Agreement, dated as of September 17, 2021, by and between Craig-Hallum Capital Group LLC and Aehr Test Systems |
| 10.17(22) | Equity Distribution Agreement, dated as of February 7, 2023, by and among William Blair & Company L.L.C., Craig-Hallum Capital Group LLC and Aehr Test Systems |
| 10.18(23) | Fourth Amendment dated December 5, 2022 for facilities located at 400 Kato Terrace, Fremont, California. |
| 10.19(24) | 2023 Equity Incentive Plan |
| 19.1 | Aehr Test Systems Insider Trading Policy (filed herewith). |
| 21.1(25) | Subsidiaries of the Company. |
| 23.1 | Consent of BPM LLP - Independent Registered Public Accounting Firm (filed herewith). |
| 31.1 | Certification Statement of Chief Executive Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002 (filed herewith). |
| 31.2 | Certification Statement of Chief Financial Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002 (filed herewith). |
| 32.1 | Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith). |
| 32.2 | Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith). |
| 97.1(26) | Aehr Test Systems Policy for Recovery of Erroneously Awarded Compensation, effective as of August 14, 2023 |
| 101.INS | XBRL Instance Document |
| 101.SCH | XBRL Taxonomy Extension Schema Document |
| 101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.DEF | XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB | XBRL Taxonomy Extension Label Linkbase Document |
| 101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
| (1) | Incorporated by reference to the same-numbered exhibit previously filed with the Company’s Registration Statement on Form S-1 filed June 11, 1997 (File No. 333-28987). |
| (2) | Incorporated by reference to Exhibit 3.1 previously filed with the Company’s Current Report on Form 8-K filed February 28, 2025 (File No. 000-22893). |
| (3) | Incorporated by reference to the same-numbered exhibit previously filed with Amendment No.1 to the Company’s Registration Statement on Form S-1 filed July 17, 1997 (File No. 333-28987). |
| (4) | Incorporated by reference to Exhibit 10.2 previously filed with the Company’s Current Report on Form 8-K filed September 28, 2016 (File No. 000-22893). |
| (5) | Incorporated by reference to Exhibit 4.3 previously filed with the Company’s Annual Report on Form 10-K filed August 27, 2021 (File No. 000-22893). |
| (6) | Incorporated by reference to Exhibit 4.2 previously filed with the Company’s Registration Statement on Form S-8 filed November 14, 2016 (File No. 333-214589). |
| (7) | Incorporated by reference to Appendix A of the Company’s Definitive Proxy Statement filed September 26, 2019 (File No. 333-214589). |
| (8) | Incorporated by reference to Exhibit 10.4 previously filed with Amendment No.1 to the Company’s Registration Statement on Form S-1 filed July 17, 1997 (File No. 333-28987). |
| (9) | Incorporated by reference to Exhibit 10.14 previously filed with the Company’s Form 10-K for the year ended May 31, 2001 filed August 29, 2001 (File No. 000-22893). |
| (10) | Incorporated by reference to Exhibit 10.12 exhibit previously filed with the Company’s Form 10-K for the year ended May 31, 1999 filed August 30, 1999 (File No. 000-22893). |
| (11) | Incorporated by reference to Exhibit 10.15 previously filed with the Company’s Current Report on Form 8-K filed May 9, 2008 (File No. 000-22893). |
| (12) | Incorporated by reference to Exhibit 10.1 previously filed with the Company’s Current Report on Form 8-K filed November 12, 2014 (File No. 000-22893). |
| (13) | Incorporated by reference to Exhibit 10.1 previously filed with the Company’s Current Report on Form 8-K filed March 2, 2018 (File No. 000-22893). |
| (14) | Incorporated by reference to Exhibit No. 10.1 previously filed with the Company's Current Report on Form 8-K filed January 9, 2012 (File No. 000-22893). |
| (15) | Incorporated by reference to Exhibit No. 10.1 previously filed with the Company's Current Report on Form 8-K filed March 8, 2013 (File No. 000-22893). |
| (16) | Incorporated by reference to Exhibit No. 10.1 previously filed with the Company's Current Report on Form 8-K filed September 6, 2024 (File No. 000-22893). |
| (17) | Incorporated by reference to Exhibit No. 10.2 previously filed with the Company's Current Report on Form 8-K filed March 8, 2013 (File No. 000-22893). |
| (18) | Incorporated by reference to Exhibit 10.19 previously filed with the Company’s Annual Report on Form 10-K filed August 29, 2017 (File No. 000-22893). |
| (19) | Incorporated by reference to Exhibit 10.20 previously filed with the Company’s Annual Report on Form 10-K filed August 29, 2017 (File No. 000-22893). |
| (20) | Incorporated by reference to Exhibit 10.1 previously filed with the Company’s Current Report on Form 8-K filed September 28, 2016 (File No. 000-22893). |
| (21) | Incorporated by reference to Exhibit 1.1 previously filed with the Company’s Current Report on Form 8-K filed September 17, 2021 (File No. 000-22893). |
| (22) | Incorporated by reference to Exhibit 4.3 previously filed with the Company’s Annual Report on Form 10-K filed August 27, 2021 (File No. 000-22893). |
| (23) | Incorporated by reference to Exhibit 10.1 previously filed with the Company’s Current Report on Form 8-K filed December 5, 2022 (File No. 000-22893). |
| (24) | Incorporated by reference to Exhibit 99.1 of the Company’s S-8 filed October 27, 2023 (File No. 333-275202). |
| (25) | Incorporated by reference to Exhibit 21.1 previously filed with the Company’s Annual Report on Form 10-K filed August 27, 2021 (File No. 000-22893). |
| (26) | Incorporated by reference to Exhibit 97 previously filed with the Company’s Annual Report on Form 10-K filed July 30, 2024 (File No. 000-22893). |
- Management contracts or compensation plans or arrangements in which directors or executive officers are eligible to participate.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.